IPO Calendar
Lead Manager
- J P Morgan Chase (471)
- Goldman Sachs (447)
- Morgan Stanley (400)
- Bank of America Merrill Lynch (347)
- Citigroup (217)
- Jefferies (204)
- Credit Suisse (180)
- Barclays (142)
- Cowen and Company (140)
- Deutsche Bank (81)
- Piper Jaffray (70)
- Leerink Partners (68)
- Stifel (61)
- UBS Investment Bank (50)
- Evercore (49)
- RBC Capital (49)
- BMO Capital (48)
- Wells Fargo (44)
- William Blair (36)
- Raymond James (34)
More +
IPO - Pricing (14)
Evercore
| UnderWriters* | |||||||||||
| Date | Company Name | Sector | Price ($) |
Size (M) |
1 | 2 | 3 | Rank | Turnover | Gain | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 11 | 4D Molecular Th | Health-Care | 23 | 8 | GS | BAML | EVCR | 43.5% | 76.1% | ||
| Oct 30 | SQZ Biotechnolo | Health-Care | 16 | 4 | BAML | EVCR | Stifel | 19.2% | -17.2% | ||
| Oct 30 | Atea Pharmaceut | Health-Care | 24 | 12 | JPM | MS | EVCR | 28.6% | 26.4% | ||
| Oct 16 | PRAXIS PRECISIO | Health-Care | 19 | 10 | COWN | EVCR | WBSH | 43.2% | 46.3% | ||
| Oct 14 | Codiak BioScien | Health-Care | 15 | 5 | GS | EVCR | WB | 41.3% | -19.2% | ||
| Oct 8 | fuboTV Inc. (fo | Consumer-Services | 10 | 18 | EVCR | 58.8% | 2.6% | ||||
| Oct 2 | Oncorus Inc. | Health-Care | 15 | 5 | JEFF | EVCR | PPRJ | 12.6% | 6.7% | ||
| Oct 2 | C4 Therapeutics | Health-Care | 19 | 9 | JEFF | EVCR | BMO | 20.3% | 34.2% | ||
| Aug 19 | Inhibrx Inc. | Health-Care | 17 | 7 | JEFF | EVCR | CS | 6.4% | 21.5% | ||
| Aug 18 | COMPASS Pathway | Health-Care | 17 | 7 | COWN | EVCR | 40% | 70.6% | |||
| Aug 7 | Freeline Therap | Health-Care | 18 | 8 | JPM | MS | EVCR | 31.5% | 0% | ||
| Jul 16 | Trean Insurance | Finance | 15 | 10 | JPM | EVCR | WB | 71.2% | 3.4% | ||
| Jul 10 | Nkarta Inc. | Health-Care | 18 | 14 | COWN | EVCR | Stifel | 9.4% | 166.1% | ||
| May 21 | SelectQuote Inc | Finance | 20 | 28 | CS | MS | EVCR | 71.4% | 35% | ||
*
Lead manager or one of top three managers in an underwriting team.